PHOENIX, Nov. 6, 2015 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Endeavor IP (OTCBB: ENIP), Hemp (OTCMKTS: HEMP), Elite Pharmaceuticals (OTCMKTS: ELTP), Roadships (OTCMKTS: TTCM), Eventure Interactive (OTCBB: EVTI), and KollagenX (OTCMKTS: KGNX).
(Read full report by clicking the links below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Endeavor IP Inc (OTCBB: ENIP): By the end of last trading, the Endeavor IP (OTCBB: ENIP) shares soared 80.00% (or US$0.00040) to US$0.00090 with about 213.77 million shares changing hands for the session, compared to its average volume of 59.57 million shares. Between October 2014 and July 2015, the company was forced to issue more than 412 million shares (about 59% of the most recently reported O/S count) as a conversion of US$329 thousand worth of debt, which means an average conversion rate of US$0.0007 per share. After July 31, the company converted some more notes and printed at least 99 million shares at an average rate of just US$0.00006 per share. Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report here.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/110615A/ENIP/EndeavorIP.pdf
Hemp Inc (OTCMKTS: HEMP): By the end of last trading, the Hemp (OTCMKTS: HEMP) shares declined 12.16% (or US$0.0090) to US$0.0650 with about 7.59 million shares changing hands for the session, compared to its average volume of 3.16 million shares. The company needs to be in a position to capitalize on the vast and largely empty hemp market, so that it can create investor value in the long run through being successful, but the latest financial report cannot convince investors it. Is there any insider trading in this company? Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report here.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/110615A/HEMP/Hemp.pdf
Elite Pharmaceuticals Inc (OTCMKTS: ELTP): By the end of last trading, the Elite Pharmaceuticals (OTCMKTS: ELTP) shares soared 27.27% (or US$0.120) to US$0.560 with about 1.53 million shares changing hands for the session, compared to its average volume of 0.15 million shares. The company actually set a new revenue record in this quarter, and president Hakim remarked he was "extremely pleased" with the quarterly performance. This good news seems to be the primary driver behind its explosive chart surge that took it to fresh 52-week highs. Is this company running promotion by penny stock promoter? Is there any insider trading in this company? Read full report here.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/110615A/ELTP/ElitePharmaceuticals.pdf
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Roadships Hldg Inc (OTCMKTS: TTCM):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/110615A/TTCM/Roadships.pdf
Eventure Interactive Inc (OTCBB: EVTI):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/110615A/EVTI/EventureInteractive.pdf
KollagenX Corp (OTCMKTS: KGNX):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/110615A/KGNX/KollagenX.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Pennystocksinsiders.com:
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.
Logo: http://photos.prnewswire.com/prnh/20150123/170935
SOURCE Pennystocksinsiders.com
Share this article